Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke

Acta Haematologica

Volumn 125, Issue 3, 2011, Pages 103-106

  Savage, William J ^a,b,c   Everett, Allen D ^b   Casella, James F ^b  

^a Division of Transfusion Medicine   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Carnegie 667 ^*  (United States)

Author keywords

Chronic transfusion; Glial fibrillary acidic protein; Sickle cell; Stroke

Indexed keywords

CEFTRIAXONE; GLIAL FIBRILLARY ACIDIC PROTEIN; INFUSION FLUID; KETOROLAC; MORPHINE; OXYCODONE; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APHASIA; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER FLOWMETRY; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FECES INCONTINENCE; FEVER; FOLLOW UP; HEMIPLEGIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; HYPOXEMIA; LEUKOCYTE COUNT; MALE; MENINGITIS; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OXYGEN THERAPY; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; STROKE; THORAX PAIN; URINE INCONTINENCE; VOMITING; WEAKNESS; WHITE MATTER;

ACUTE DISEASE; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; CHILD; EXCHANGE TRANSFUSION, WHOLE BLOOD; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; STROKE;

EID: 78449236995     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321791     Document Type: Article

References (17)

1. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288-.294. (Pubitemid 28018756)
2. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT: Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol 2009; 84: 618-.625.
3. Verduzco LA, Nathan DG: Sickle cell disease and stroke. Blood 2009; 114: 5117-.5125.
4. Adams RJ, Brambilla D: Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005; 353: 2769-.2778. (Pubitemid 43016816)
5. Woertgen C, Rothoerl RD, Wiesmann M, Missler U, Brawanski A: Glial and neuronal serum markers after controlled cortical impact injury in the rat. Acta Neurochir Suppl 2002; 81: 205-.207.
6. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ: Release of glial tissuespecific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000; 31: 2670-.2677.
7. Wunderlich MT, Wallesch CW, Goertler M: Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol 2006; 13: 1118-.1123. (Pubitemid 44434318)
8. Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM: Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004; 62: 1303-.1310. (Pubitemid 38526041)
9. Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ: An ELISA for glial fibrillary acidic protein. J Immunol Methods 2004; 287: 169-.177. (Pubitemid 38510218)
10. Osterlundh G, Kjellmer I, Lannering B, Rosengren L, Nilsson UA, Marky I: Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children. Pediatr Blood Cancer 2008; 50: 793-.798. (Pubitemid 351354787)
11. Eng LF, Ghirnikar RS, Lee YL: Glial fibrillary acidic protein: GFAP -. thirty-one years (1969-.2000). Neurochem Res 2000; 25: 1439-. 1451.
12. Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A: Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma 2004; 57: 1006-.1012. (Pubitemid 39579285)
13. Blennow M, Hagberg H, Rosengren L: Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants? Pediatr Res 1995; 37: 260-.264.
14. Hsu AA, Fenton K, Weinstein S, Carpenter J, Dalton H, Bell MJ: Neurological injury markers in children with septic shock. Pediatr Crit Care Med 2008; 9: 245-.251. (Pubitemid 351677679)
15. Jung CS, Foerch C, Schanzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe A, Sitzer M: Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain 2007; 130: 3336-.3341. (Pubitemid 350209077)
16. Scothorn DJ, Price C, Schwartz D, Terrill C, Buchanan GR, Shurney W, Sarniak I, Fallon R, Chu JY, Pegelow CH, Wang W, Casella JF, Resar LS, Berman B, Adamkiewicz T, Hsu LL, Ohene-Frempong K, Smith-Whitley K, Mahoney D, Scott JP, Woods GM, Watanabe M, Debaun MR: Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002; 140: 348-.354. (Pubitemid 34289713)
17. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5-.11. (Pubitemid 28304491)